199 related articles for article (PubMed ID: 31615645)
21. [Harmonization of data coding in post-transplant follow-up - "GVHD, complications and additional treatments": Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Cornillon J; Detrait M; Karam M; Le Bars L; Meziane Y; Pereira M; Richard-Leveille S; Marion S; Leroux S; Coiteux V; Raus N; Seris S; Guyotat D; Yakoub-Agha I; Laurent N
Bull Cancer; 2019 Jan; 106(1S):S71-S82. PubMed ID: 30448095
[TBL] [Abstract][Full Text] [Related]
22. [Assessment and management of post-transplant iron overload: Guidelines of the Francophone Society of Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Jaspers A; Bouhya S; Belaiche S; Chevallier P; Hermet E; Hospital-Gustems C; Michallet M; Rialland F; Samsonova O; Sirvent A; Yakoub-Agha I; Rohrlich PS; Beguin Y
Bull Cancer; 2016 Nov; 103(11S):S255-S266. PubMed ID: 27842863
[TBL] [Abstract][Full Text] [Related]
23. [National care logbook for patients undergoing autologous hematopoietic cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Porcheron S; Balcaen S; Cardinael N; Courbon C; Dendoncker C; Faivre-Lescat H; François G; Gilis L; Guiraud M; Schmitt S; Vercasson M; Adam C; Yakoub-Agha I
Bull Cancer; 2017 Dec; 104(12S):S142-S144. PubMed ID: 29128082
[TBL] [Abstract][Full Text] [Related]
24. [Information booklet for related hematopoietic stem cell donors: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Polomeni A; Tardieu L; Ainaoui M; Andrianne C; Bancillon N; Chapel V; Chevallier N; Evrard S; Fournier I; Gargallo G; Godin S; Issarni D; Le Bars L; Renaud B; Yakoub-Agha I; Wallart A; De Bentzmann N
Bull Cancer; 2017 Dec; 104(12S):S71-S75. PubMed ID: 29126585
[TBL] [Abstract][Full Text] [Related]
25. Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation.
Koenecke C; Göhring G; de Wreede LC; van Biezen A; Scheid C; Volin L; Maertens J; Finke J; Schaap N; Robin M; Passweg J; Cornelissen J; Beelen D; Heuser M; de Witte T; Kröger N;
Haematologica; 2015 Mar; 100(3):400-8. PubMed ID: 25552702
[TBL] [Abstract][Full Text] [Related]
26. [Renal failure after allogeneic hematopoietic stem cell transplantation: Recommendations of the Francophone Society of Bone Marrow transplantation and cellular Therapy (SFGM-TC)].
Detrait M; de Berranger E; Dulery R; Ménard AL; Thépot S; Toprak SK; Turlure P; Yakoub-Agha I; Guillaume T
Bull Cancer; 2020 Jan; 107(1S):S28-S35. PubMed ID: 31303250
[TBL] [Abstract][Full Text] [Related]
27. [Indications and follow-up for autologous hematopoietic stem cell transplantation in autoimmune and autoinflammatory diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Pugnet G; Castilla-Llorente C; Puyade M; Terriou L; Badoglio M; Deligny C; Guillaume-Jugnot P; Labeyrie C; Benzidia I; Faivre H; Lansiaux P; Marjanovic Z; Bourhis JH; Faucher C; Furst S; Huynh A; Martin T; Vermersch P; Yakoub-Agha I; Farge D
Bull Cancer; 2017 Dec; 104(12S):S169-S180. PubMed ID: 29173974
[TBL] [Abstract][Full Text] [Related]
28. [Oral feeding of patient hospitalized for allogeneic stem cells transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Dendoncker C; Brouillat C; Daufrene L; Deledicque V; El Cheikh J; Gibault-Joffe C; Guilbert Y; Guidi V; Hadrot L; Haran I; Kermeur G; Kernoa K; L'Hostette A; Mercier L; Mouneydier K; Servais S; Withofs S; Yakoub-Agha I; Farrugia C
Bull Cancer; 2020 Jan; 107(1S):S36-S43. PubMed ID: 31615648
[TBL] [Abstract][Full Text] [Related]
29. Cytogenetics in the management of myeloproliferative neoplasms, mastocytosis and myelodysplastic/myeloproliferative neoplasms: Guidelines from the Group Francophone de Cytogénétique Hématologique (GFCH).
Decamp M; Klein E; Godon C; Lestringant V; Roynard P; Theisen O; Jimenez-Pocquet M; Roche-Lestienne C; Bidet A; Veronese L
Curr Res Transl Med; 2023; 71(4):103424. PubMed ID: 38011761
[TBL] [Abstract][Full Text] [Related]
30. [Hematological toxicities post-CAR-T cells: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Alsuliman T; Aubrun C; Bay JO; Beguin Y; Bigenwald C; Brissot E; Chalandon Y; Chevallier P; Pagliuca S; Magro L; Srour M
Bull Cancer; 2024 Apr; ():. PubMed ID: 38631984
[TBL] [Abstract][Full Text] [Related]
31. [National patient follow-up care logbook: Guidelines by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
de Berranger E; Balcaen S; Ainaoui M; Bompoint C; Borel C; Chevallier N; de Bentzmann N; Denis V; Kerautret K; Godin S; Labat ML; Letort-Bertrand M; Porcheron S; Magro L; Yakoub-Agha I; Guiraud M
Bull Cancer; 2016 Nov; 103(11S):S273-S275. PubMed ID: 27776733
[TBL] [Abstract][Full Text] [Related]
32. [From conventional cytogenetics to microarrays. Fifty years of Philadelphia chromosome].
Hernández JM; Granada I; Solé F;
Med Clin (Barc); 2011 Jul; 137(5):221-9. PubMed ID: 20591449
[TBL] [Abstract][Full Text] [Related]
33. [Therapeutic Education Programs for the Patient (ETP) undergoing an allogeneic hematopoietic cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Cheron N; Riou M; Babouche I; Chevallier N; Aimee Dann MP; Delorme J; Denis V; Girard I; Godin S; Tardieu L; Yakoub-Agha I
Bull Cancer; 2021 Dec; 108(12S):S26-S29. PubMed ID: 34865834
[TBL] [Abstract][Full Text] [Related]
34. A nationwide survey of co-occurrence of malignant lymphomas and myelodysplastic syndromes/myeloproliferative neoplasms.
Sakata-Yanagimoto M; Yokoyama Y; Muto H; Obara N; Kurita N; Kato T; Hasegawa Y; Miyazaki Y; Kurokawa M; Chiba S
Ann Hematol; 2016 Apr; 95(5):829-30. PubMed ID: 26891876
[No Abstract] [Full Text] [Related]
35. Defining the Boundary Between Myelodysplastic Syndromes and Myeloproliferative Neoplasms.
Loghavi S; Wang SA
Surg Pathol Clin; 2019 Sep; 12(3):651-669. PubMed ID: 31352979
[TBL] [Abstract][Full Text] [Related]
36. [Hepatobiliary complications following allogeneic hematopoietic cell transplantation: Recommendations of the Francophone Society of Bone Marrow transplantation and cellular Therapy (SFGM-TC)].
Detrait M; de Berranger E; Dulery R; Ménard AL; Thépot S; Toprak SK; Turlure P; Yakoub-Agha I; Guillaume T
Bull Cancer; 2020 Jan; 107(1S):S18-S27. PubMed ID: 30952358
[TBL] [Abstract][Full Text] [Related]
37. [Donor Lymphocyte Infusions (DLI): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
De Vos J; Baudoux E; Bay JO; Calmels B; Cras A; El Cheikh J; Guerout-Verite MA; Lacassagne MN; Lamure S; Letellier C; Menard AL; Daguindau E; Poiré X; Yakoub-Agha I; Guillaume T
Bull Cancer; 2019 Jan; 106(1S):S35-S39. PubMed ID: 30580911
[TBL] [Abstract][Full Text] [Related]
38. [Dose adaptation of the drugs used for hematopoietic stem-cell transplantation in patients with comorbidity: Obesity, chronic renal disease or hepatopathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Simon N; Coiteux V; Bruno B; Taque S; Charbonnier A; Souchet L; Vincent L; Yakoub-Agha I; Chalandon Y
Bull Cancer; 2017 Dec; 104(12S):S99-S105. PubMed ID: 29173979
[TBL] [Abstract][Full Text] [Related]
39. Clinical units to set up chimeric antigen receptor T-cell therapy (CAR T-cells): Based on the recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).
Yakoub-Agha I
Curr Res Transl Med; 2018 May; 66(2):57-58. PubMed ID: 29685843
[TBL] [Abstract][Full Text] [Related]
40. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
